D-dopa: Difference between revisions
No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
| cat=sd | | cat=sd | ||
| image= [[Image:D-DOPA Line.png|210px|D-DOPA Line]] | | image= [[Image:D-DOPA Line.png|210px|D-DOPA Line]] | ||
| name=(R)-2-amino-3-(3,4-dihydroxyphenyl)-propanoic acid | | name=(R)-2-amino-3-(3,4-dihydroxyphenyl)-propanoic acid | ||
| <!-- abbreviations=D-DOPA --> | | <!-- abbreviations=D-DOPA --> | ||
| Line 19: | Line 18: | ||
{{SI}} | {{SI}} | ||
'''D-DOPA''' (Dextrodopa) is similar to [[L-DOPA]] (levodopa, 3,4-dihydroxy-L-phenylalanine), but differs in its property of [[dextrorotation]]. Levo- and dextro- rotation reference a molecules ability to rotate planes of [[polarized light]] in either direction. | '''D-DOPA''' (Dextrodopa) is similar to [[L-DOPA]] (levodopa, 3,4-dihydroxy-L-phenylalanine), but differs in its property of [[dextrorotation]]. Levo- and dextro- rotation reference a molecules ability to rotate planes of [[polarized light]] in either direction. | ||
| Line 29: | Line 28: | ||
[[Category:Aromatic amino acids]] | [[Category:Aromatic amino acids]] | ||
Latest revision as of 00:26, 9 August 2012
|
WikiDoc Resources for D-dopa |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on D-dopa at Clinical Trials.gov Clinical Trials on D-dopa at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on D-dopa
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating D-dopa Risk calculators and risk factors for D-dopa
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
D-DOPA (Dextrodopa) is similar to L-DOPA (levodopa, 3,4-dihydroxy-L-phenylalanine), but differs in its property of dextrorotation. Levo- and dextro- rotation reference a molecules ability to rotate planes of polarized light in either direction.
While L-Dopa is moderately effective against the loss of natural dopamine in Parkinson's disease, D-Dopa is biologically inactive. D- dopa is L- Dopa's enantiomer. See L-DOPA for more information about DOPA in general.